Precision Biosciences (DTIL) Non-Current Assets (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Non-Current Assets data on file, last reported at $35.2 million in Q1 2026.

• On a quarterly basis, Non-Current Assets fell 16.81% year-over-year to $35.2 million in Q1 2026; TTM through Mar 2026 was $151.3 million, a 2.12% increase from a year earlier, with the FY2025 full-year figure at $35.7 million, down 13.82% from the prior year.
• Non-Current Assets for Q1 2026 stood at $35.2 million, down from $35.7 million in the prior quarter.
• Over the last five years, Non-Current Assets for DTIL reached as high as $49.5 million in Q2 2022 and fell as low as $18.5 million in Q3 2023.
• Historically, Non-Current Assets has averaged $36.3 million across 5 years, with a median of $38.7 million in 2025.
• Across the five-year window, Non-Current Assets plunged 60.12% in 2023 and soared 131.1% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $39.1 million in 2022, then slumped by 40.04% to $23.4 million in 2023, then surged by 76.75% to $41.4 million in 2024, then fell by 13.82% to $35.7 million in 2025, then dropped by 1.34% to $35.2 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $35.2 million in Q1 2026, $35.7 million in Q4 2025, and $41.8 million in Q3 2025.